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Background: Given the importance of timing of denudation and oocyte injection during 
assisted reproductive technology cycles, a study was undertaken of the impact of timing on 
the outcome of intracytoplasmic sperm injection in a cohort of patients from a private in vitro 
fertilization center.
Methods: The study included patients who underwent fresh intracytoplasmic sperm injection-
embryo transfer by a single embryologist and gynecologist over a two-year period (January 2008 
to March 2010). The primary outcome measure was the number of mature oocytes, and clinical 
pregnancy was the secondary outcome measure.
Results: There was no significant difference between the three groups with respect to female 
age, but Group 3 showed a higher mean number of cumulus oopherus (14.46 versus 14.19), 
mature oocytes at time of denudation (12.72 versus 11.71), metaphase II injected (13.04 versus 
11.85), and fertilized oocytes (9.75 versus 8.25) than Group 2. Group 2 showed a higher number 
of cumulus oopherus (14.19 versus 13.11), mature oocytes at time of denudation (11.71 versus 
9.37), metaphase II injected (11.85 versus 9.7), and fertilized oocytes (8.25 versus 6.86) than 
Group 1. The maturation index, as well as positive clinical pregnancies, was significantly higher 
in Group 2 than Group 1 and in Group 3 compared with Group 1. Comparing Group 2 and 
Group 3, there was no significant difference regarding clinical pregnancy rates.
Conclusion: It is preferable to allow an interval between oocyte retrieval and sperm 
injection.
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Introduction
Approximately 20% of oocytes routinely retrieved following hormone stimulation are 
classified as immature (termed germinal vesicle, or metaphase I stage). These oocytes 
are discarded due to their reduced potential for embryo development under current 
culture conditions.1 The cumulus cells that surround oocytes within follicles modulate 
nuclear and cytoplasmic maturation by both physical cell-cell contact and the   combined 
actions of paracrine factors.2 However, during the process of   intracytoplasmic sperm 
injection, cumulus cells must be removed from oocytes, which normally would mature 
the oocytes.3
A prolonged interval between human chorionic gonadotrophin administration and 
oocyte retrieval in conventional controlled ovarian hyperstimulation cycles increases 
the production of oocytes and embryo developmental competence.4,5
The cumulus cells were deemed to be expanded when they had cells detached 
from the oocyte with matrix visible between cumulus cells.6,7 In 2009, Vanhoutte et al International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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  concluded that during conventional in vitro maturation, 
oocytes undergo nuclear maturation, but do not attain full 
cytoplasmic maturity, while the in vitro maturation of oocytes 
in the presence of granulosa cells in the culture   system 
  promoting cytoplasmic maturation was assessed by the 
oocytes’ capability to fertilize after intracytoplasmic sperm 
injection and sustain further embryonic development.
Materials and methods
The present study was conducted at the In Vitro Fertilization 
Unit at Soliman Fakih Hospital, Saudi Arabia. Three hundred 
and nine intracytoplasmic sperm injection-embryo transfers 
were performed by a single provider and a single embryologist 
over a two-year period of time. Patients were divided into 
three groups, ie, Group 1 (oocyte denudation and injection 
done immediately after ovum pickup in intracytoplasmic 
sperm injection–embryo transfer cycles), Group 2 (oocyte 
denudation and injection, each done within one hour of ovum 
pickup in intracytoplasmic sperm injection–embryo transfer 
cycles) and Group 3 (oocyte denudation and injection, each 
done within two hours of ovum pickup in intracytoplasmic 
sperm injection–embryo transfer cycles).
Participants were selected from those attending the 
infertility clinic, and each woman was subjected to the 
following hormonal profile (follicle-stimulating hormone, 
luteinizing hormone, prolactin, and estradiol) and ultrasound 
examination. The women were aged up to 39 years, and had 
normal baseline follicle-stimulating hormone levels, body 
mass index #30, with no uterine abnormalities. Women 
with partners having sufficient numbers of spermatozoa for 
oocyte injection, bilateral undescended testes, or Klinefelter’s 
syndrome were excluded from the study. All patients had 
undergone controlled ovarian stimulation by the   antagonist 
protocol. The dose of gonadotropins was   individualized, 
based on the patient’s age, history, and response to 
medication. Cycles were monitored using serial transvaginal 
ultrasound to assess follicular growth.
Oocyte collection
Oocyte maturation was induced by the administration of 
10,000 IU of human chorionic gonadotrophin (Pregnyl®, NV 
Organon) when at least three follicles $17 mm diameter were 
present on ultrasound scan. Retrieval of oocytes was done 
approximately 36 hours after human chorionic gonadotrophin 
administration, and was performed under transvaginal 
ultrasound guidance. The aspirates were collected in tubes 
with prewarmed Earle’s Balanced Salt Solution. Collection 
started with the largest follicle, and oocyte maturity was 
assessed. Subsequent collection of oocytes without follicle 
size measurement was performed according to accessibility 
of the follicles, after which the maturity level of the oocyte 
was identified under a stereomicroscope.
For Group 2 and Group 3, the oocytes collected were 
placed in a central well dish with 1 mL GIVF media 
and placed in the incubator, but immediate dissection 
was done in Group 1 under the dissecting microscope 
with high magnification. The cumulus masses were 
removed with hyaluronidase and mechanical pipetting, and 
assessment of maturity was undertaken. The nuclear status 
of denuded oocytes was subsequently recorded. Germinal 
vesicle oocytes were not considered for intracytoplasmic 
sperm injection. Metaphase I oocytes were defined as those 
in which no germinal vesicle and no first polar body were 
visible. Metaphase I oocytes were left to mature until the 
time when intracytoplasmic sperm injection was carried 
out. Mature oocytes in metaphase II were injected on the 
same day. Intracytoplasmic sperm injection was performed 
according to the method described by Van Steirtegham et al8 
and Al-Hasani et al.9 Matured oocytes were injected 
by intracytoplasmic sperm injection using the partner’s 
spermatozoa. Intracytoplasmic sperm injection was 
performed in Group 2 and Group 3 after one hour10 and two 
hours, respectively, but immediate injection was done in 
Group 1.
embryo development and transfer
Injected oocytes were cultured in G1 media, and   fertilization 
was assessed 16–20 hours after injection for the appearance 
of two distinct pronuclei and two polar bodies. Embryonic 
development was assessed on day 2 (44–48 hours) and 
on day 3 (67–72 hours) after intracytoplasmic sperm injec-
tion according to the number of blastomeres, fragmentation 
rate, cell size, symmetry, granulation, vacuolization, and 
multinucleation, and all dysmorphic characteristics of 
the embryos were noted. The best quality embryos were 
transferred on days 2 or 3 after intracytoplasmic sperm 
injection according to the method described by   Schoolcraft 
et al.11 All embryo transfers were performed with a full 
bladder under ultrasound guidance using the Labotect 
catheter (Labotect, Göttingen, Germany) and the Hamilton 
syringe (Reno, NV) by the same gynecologist and single 
embryologist.
Follow-up
Pregnancy was diagnosed by the detection of positive 
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embryo   transfer, followed by a rise in human chorionic 
gonadotrophin levels. All patients underwent a transvaginal 
ultrasound scan at 6–7 weeks of pregnancy to differentiate 
between biochemical and clinical (presence of an intrauterine 
  gestational sac with fetal heart beat) pregnancies and to 
diagnose ectopic implantations.
statistical analysis
The statistical analysis was done with the SPSS program 
for Microsoft Windows (Chicago, IL) using the Student’s 
t-test or Fisher’s Exact test as appropriate. The primary 
outcome analyzed was the number of mature oocytes, and 
the secondary outcome was clinical pregnancy rate per 
transfer, as defined by the presence of a gestational sac on 
ultrasound at 6–8 weeks of gestation. Cases with no rising 
human chorionic gonadotrophin titer were not scored as 
clinical pregnancies.
Results
The average (standard deviation) age of the patients was 
29 ± 4 years. The overall pregnancy rate was 41.1%. 
Group 1 included 132 intracytoplasmic sperm   injection–
embryo transfers in which oocyte denudation followed ovum 
pickup immediately and was followed by oocyte injection 
immediately as well. Group 2 included 72 intracytoplasmic 
sperm injection–embryo transfers in which oocyte denudation 
was followed by ovum pickup with approximately one 
hour in vitro culture, and followed later by oocyte injection 
within one hour in vitro culture. Group 3 included 
105 intracytoplasmic sperm injection–embryo transfers 
in which oocyte denudation followed ovum pickup, with 
approximately two hours of in vitro culture, and followed later 
by oocyte injection within two hours of in vitro culture.
As shown in Table 1, there was no significant difference 
between groups 1, 2, and 3 for age (28.75, 28.78, and 
29.63 years, respectively), but Group 3 showed a higher 
mean number of cumulus oopherus (14.46 versus 14.19), 
mature oocytes at time of denudation (12.72 versus 11.71), 
metaphase II injected (13.04 versus 11.85), and fertilized 
oocytes (9.75 versus 8.25) than Group 2. Group 2 showed a 
higher number of cumulus oopherus (14.19 versus 13.11), 
mature oocytes at time of denudation (11.71 versus 9.37), 
metaphase II injected (11.85 versus 9.7), and fertilized 
oocytes (8.25 versus 6.86) than Group 1.
The maturation index, as well as positive clinical 
pregnancy, was significantly higher in Group 2 than in 
Group 1, and in Group 3 compared with Group 1, but there 
was no significant difference between Group 2 and Group 3 
for clinical pregnancy rates (Table 2).
Discussion
In our study, Group 3 showed a significantly higher maturation 
index than Group 2 (P = 0.000), and Group 2 showed a higher 
maturation index than Group 1 (P = 0.000). This is in 
agreement with a previous report,12 describing a significantly 
higher number of oocytes with fully expanded cumulus 
cells after delayed oocyte retrieval (39 hours) in patients 
with polycystic ovary syndrome and controlled ovarian 
hyperstimulation cycles. Weon-Young et al,13 also reported 
a positive correlation between the number of oocytes with 
a dispersed cumulus cell pattern at the time of denudation 
and an increasing time interval between human chorionic 
gonadotrophin and oocyte denudation, and Bokal et al4 
found a significantly higher number of metaphase II oocytes 
in their human chorionic gonadotrophin + 38-hour group 
than in their human chorionic gonadotrophin + 34 hours 
group in controlled ovarian hyperstimulation cycles, resulting 
in higher clinical pregnancy rates. This was attributed to 
the increased quantity of embryos available to select for 
transfer.
Bokal et al4 suggested that longer exposure to human 
chorionic gonadotrophin increased follicular vascularization 
and, thus, oocyte quality, due to a high concentration of 
vascular endothelial growth factor. However, in in vitro 
Table 1 clinical and demographic data
Group 1 Group 2 Group 3
Mean SD Sum Mean SD Sum Mean SD Sum
Women’s age (years) 28.75 4.02 28.78 3.85 29.63 4.7
Hours from injection (n) 36.3 0.42 38.23 0.31 40.58 0.957
cumulus oopherus (n) 13.11 5.05 1731 14.19 6.09 1022 14.46 6.5 1518
Mature oocytes (n) 9.37 4.18 1237 11.71 5.52 843 12.72 5.96 1336
Oocytes injected (n) 9.7 4.28 1281 11.85 5.56 853 13.04 6.16 1369
Oocytes fertilized (n) 6.86 3.51 906 8.25 4.35 594 9.75 5.24 1024
good embryos transferred (n) 3.72 1.15 3.43 1.38 3.15 1.59
Abbreviation: sD, standard deviation.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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maturation cycles, it is hard to confirm the effect of   vascular 
endothelial growth factor because it is difficult to get 
follicular fluid from each follicle due to their small size. 
Another possibility could be that even though there is no 
direct evidence of the appearance of luteinizing hormone 
receptors in folliculogenesis, it is possible that some small 
follicles with an insufficient number of luteinizing hormone 
receptors might have responded following exposure for a 
longer time to human chorionic gonadotrophin (35 versus 
38 hours), resulting in an increased number of oocytes with 
dispersed cumulus cells and a reduced number of oocytes 
with compacted or sparse cumulus cells. Interestingly, 
luteinizing hormone receptor expression has been confirmed 
in dispersed cumulus cells of oocytes generated from human 
chorionic gonadotrophin-primed in vitro maturation cycles.13 
Therefore, we believe that prolonging the interval between 
human chorionic gonadotrophin administration and oocyte 
denudation would yield a higher number of oocytes with 
expanded cumulus cells, which predict higher maturation 
rates and developmental embryonic competence.
Previous studies done in patients with polycystic ovary 
syndrome indicate that there is no risk of ovulation when 
delaying oocyte collection after human chorionic gonado-
trophin stimulation because the largest follicle size at the 
time of human chorionic gonadotrophin administration is 
8–12 mm.4,12,13 However, our study was conducted in patients 
without polycystic ovary syndrome and with controlled 
ovarian hyperstimulation cycles, and we avoided the risk of 
oocyte ovulation by placing the cumulus oopherus collected 
at the time of ovum pickup into culture media, allowing 
further in vitro maturation.
Another explanation for the higher pregnancy rates 
observed in Group 3 (P = 0.000) and Group 2 (P = 0.000) in 
comparison with Group 1 could be the delay of denudation 
and injection time interval for oocytes, allowing time for 
meiotic spindle appearance, which is in agreement with a 
report by Kilani et al14 who found that meiotic spindle appear-
ance is time-dependent, with the majority of oocytes having 
detectable spindles and highest retardance at 39.0–40.5 hours 
after human chorionic gonadotrophin administration under 
currently used stimulation protocols, after which they start to 
disaggregate. The optimal time for intracytoplasmic sperm 
injection may be 39–40.5 hours following human chorionic 
gonadotrophin, and the time of oocyte injection in our study 
was 40.58 ± 0.95 hours in Group 3, 38.23 ± 0.31 hours in 
Group 2, and 36.3 ± 0.42 hours in Group 1.
We agree with Weon-Young et al,13 that although 
numerous studies of in vitro maturation of immature human 
oocytes have been performed, compared with controlled 
ovarian hyperstimulation cycles, the efficiency of current 
in vitro maturation techniques is still suboptimal in terms 
of the number of mature oocytes obtained, developmental 
embryonic competence, and implantation rates.
We believe that further studies in a larger number of 
cases may clarify the optimal in vitro fertilization technique, 
and we are presently investigating the effects of addition of 
follicle-stimulating hormone and/or luteinizing hormone to 
the culture media, and whether the currently observed higher 
pregnancy rates are related to a delay in oocyte denudation 
and/or a delay in oocyte injection.
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